Difficult to Heal Wounds
Conditions
Keywords
VLU; difficult to heal wounds; diabete; ulcers;
Brief summary
This study aims to determine and evaluate the clinical accuracy, precision, and safety of SeeWound 2, an AI-driven wound assessment application, designed for the measurement of wound surface area (cm²), wound depth (mm), and the estimation of the proportion of fibrin covering (slough) and necrosis (%) in real-world clinical settings for patients with hard-to-heal wounds. The study also seeks to validate the non-invasive method for measuring wound depth, as current standard care involves invasive probing of the wound to estimate depth - a practice that this investigational device is intended to replace with a digital, contact-free measurement approach.
Detailed description
SeeWound 2 is a software-based medical device that utilises artificial intelligence to classify and quantify wound tissue types, specifically fibrin covering (slough) and necrosis, as well as to measure wound surface area and depth through digital image analysis. The system operates as a mobile camera-based application, whereby healthcare professionals capture an image of a hard-to-heal wound. The software then automatically analyses the image using integrated AI models in combination with the LiDAR sensor technology embedded in the mobile camera hardware. The product's capability to automatically measure wound surface area, estimate wound depth in a non-invasive manner, and objectively quantify the proportion of slough and necrosis within the wound bed represents a novel functionality not currently available in clinical practice.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
Older than 18 years, men and women Difficult to heal wounds due to diabetes, VLU; Pressure wounds wound larger than 0.5 cm2
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Accuracy | During the study | Regular outcome measures for a Medical Device |
| Accurac, Precision, Mean absolute Error (MAE); Coefficient of Variation (CV); SD | During the study | Regular outcome measures for a Medical Device |
Countries
Sweden